Bremelanotide (Synonyms: PT-141 ) CAS NO.189691-06-3

1. Our technology team has more than ten years experience of peptide synthesis and purification. The experience and know-how in the development of optimal manufacturing processes lead to achieve an outstanding product quality in high yield.

2. The well-equipped peptide center covering 1,000 m². with peptide synthesizer 50L, 20L, 5L and HPLC purification systems with different sizes, can synthesis peptide  from mg to hundreds of gram. and the center also equipped with GMP standard clean room to meet your special needs.  

3. An experienced and well-trained quality team and well-equipped test instruments have strict quality control on from raw material, peptide intermediates to the final peptide.

4. The technical consultant is ready to provide services and support in 24H for customers.

Bremelanotide

Synonyms: PT-141, Rekynda

Sequence: Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-OH      Chemical Bridge Asp2-Lys7

Molecular Formula: C50H68N14O10

CAS No.: 189691-06-3

Background: 

Bremelanotide, sold under the brand name Vyleesi, is a medication which is used to treat low sexual desire in women. It is given by aninjection into the fat of the thigh or abdomen.

Bremelanotide was developed by Palatin Technologies and was approved for use in the United States by FDA in June 21, 2019.

Remarks:

Products currently covered by valid Patents are offered for R&D use.

Any patent infringement and resulting liability is solely at buyer risk.